Episode

Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer

Podcast: The Long Run with Luke Timmerman
Published: Jul 1, 2025
Duration seconds: 3438
Processing state: not_requested
Canonical source: https://soundcloud.com/longrunpodcast/ep181-claire-mazumdar-on-bifunctional-antibodies-for-cancer
Audio: https://feeds.soundcloud.com/stream/2122622295-longrunpodcast-ep181-claire-mazumdar-on-bifunctional-antibodies-for-cancer.mp3
JSON: /v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep181-claire-mazumdar-on-a-two-pronged-attack-against-cancer
Markdown: /podcast/the-long-run-with-luke-timmerman-1124799/ep181-claire-mazumdar-on-a-two-pronged-attack-against-cancer.md

Actions

POST https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep181-claire-mazumdar-on-a-two-pronged-attack-against-cancer/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep181-claire-mazumdar-on-a-two-pronged-attack-against-cancer.md
Read the agent-friendly Markdown representation of this episode resource.

Claire Mazumdar, CEO of Boston-based Bicara Therapeutics, on developing a bifunctional antibody for head and neck cancer.